Owens Patrick W, McVeigh Terri P, Fahey Eoin J, Bell Marcia, Quill Denis S, Kerin Michael J, Lowery Aoife J
Discipline of Surgery, Lambe Institute for Translational Research, NUI Galway, Galway, Ireland.
Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Eur Thyroid J. 2018 Nov;7(6):319-326. doi: 10.1159/000493261. Epub 2018 Sep 28.
International best-practice guidelines recommend completion thyroidectomy and radioiodine remnant ablation (RRA) for patients with differentiated thyroid cancer (DTC) > 4 cm or with specific risk factors. Patients with DTC < 1 cm without risk factors are recommended for lobectomy alone. Indications for aggressive surgery and RRA are less clearly defined for tumours measuring 1-4 cm. A personalised approach to decision-making is recommended.
This study assesses therapeutic approaches to DTC as compared to the current British Thyroid Association (BTA) clinical practice guidelines. We ascertained the effect of equivocal guidance in the 1-4 cm tumour cohort on contemporary practice patterns.
Data were obtained from a prospectively maintained thyroid cancer database of patients treated for DTC in a tertiary referral centre at the University Hospital Galway. Consecutive patients attending a dedicated thyroid cancer clinic between August 2014 and August 2017 were included. Clinicopathological characteristics and management strategies were assessed.
Ninety-four percent ( = 168/178) of patients were surgically managed in adherence with guidelines. A minority ( = 10) received surgery not aligned with guidelines. Ninety-seven percent ( = 172/178) of RRA treatment decisions were in accordance with guidelines. The BTA guidelines recommended a personalised decision-making approach for 18.0% ( = 32) and 44.9% ( = 80) of surgery and RRA treatment decisions, respectively. The more aggressive, treatment-driven approach was typically favoured by the multidisciplinary team, with 97% ( = 31/32) undergoing completion thyroidectomy and 100% ( = 80) proceeding to RRA.
Management of DTC at our institution closely adheres to contemporary clinical practice guidelines. The finding of more aggressive management in those requiring a personalised decision-making approach highlights the requirement for improved risk stratification in this cohort to ratio-nalise management strategies.
国际最佳实践指南建议,对于直径大于4厘米或具有特定风险因素的分化型甲状腺癌(DTC)患者,应进行甲状腺全切术和放射性碘残留消融(RRA)。对于直径小于1厘米且无风险因素的DTC患者,建议仅行甲状腺叶切除术。对于直径在1 - 4厘米的肿瘤,积极手术和RRA的指征定义不太明确。建议采用个性化的决策方法。
本研究评估了与当前英国甲状腺协会(BTA)临床实践指南相比,DTC的治疗方法。我们确定了1 - 4厘米肿瘤队列中模糊指导对当代实践模式的影响。
数据来自戈尔韦大学医院三级转诊中心前瞻性维护的DTC患者甲状腺癌数据库。纳入了2014年8月至2017年8月期间在专门的甲状腺癌诊所就诊的连续患者。评估了临床病理特征和管理策略。
94%( = 168/178)的患者按照指南进行了手术管理。少数患者( = 10)接受了不符合指南的手术。97%( = 172/178)的RRA治疗决策符合指南。BTA指南分别为18.0%( = 32)的手术治疗决策和44.9%( = 80)的RRA治疗决策推荐了个性化决策方法。多学科团队通常倾向于更积极的、以治疗为导向的方法,97%( = 31/32)的患者接受了甲状腺全切术,100%( = 80)的患者进行了RRA。
我们机构对DTC的管理严格遵循当代临床实践指南。在那些需要个性化决策方法的患者中发现更积极的管理方式,凸显了在该队列中改善风险分层以合理化管理策略的必要性。